Prevacid Solutab
Product Images NDC 21695-106

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Prevacid Solutab (NDC 21695-106). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (D15c8f36 4dcc 4b28 B03c 4e81b2f9ad2e 01)

Chemical Structure (D15c8f36 4dcc 4b28 B03c 4e81b2f9ad2e 01)
Chemical structure diagram of the active ingredient in Prevacid SoluTab, showing a benzimidazole ring connected to a sulfinylmethyl group and a substituted pyridine ring.*
FDA Label Image

Figure (D15c8f36 4dcc 4b28 B03c 4e81b2f9ad2e 02)

Figure (D15c8f36 4dcc 4b28 B03c 4e81b2f9ad2e 02)
A line graph titled 'Mean Severity of Day Heartburn By Study Day For Evaluable Patients' comparing placebo, Lansoprazole 15 mg QD, and Lansoprazole 30 mg QD. The x-axis represents days from start of treatment (0 to 60), and the y-axis represents mean severity of day heartburn on a scale from 0 (none) to 3 (severe). Lansoprazole treatments show lower heartburn severity over time compared to placebo.*
FDA Label Image

Figure (D15c8f36 4dcc 4b28 B03c 4e81b2f9ad2e 03)

Figure (D15c8f36 4dcc 4b28 B03c 4e81b2f9ad2e 03)
A line graph showing the mean severity of night heartburn over 60 days from the start of treatment in evaluable patients. The graph compares placebo, Lansoprazole 15 mg QD, and Lansoprazole 30 mg QD, with severity rated from 0 (None) to 3 (Severe). Severity decreases over time for all groups, with the Lansoprazole 30 mg QD group showing the greatest reduction.*
FDA Label Image

Prevacid 30mg (D15c8f36 4dcc 4b28 B03c 4e81b2f9ad2e 04)

Prevacid 30mg (D15c8f36 4dcc 4b28 B03c 4e81b2f9ad2e 04)
Prevacid SoluTab 30 mg capsules, bottle label for a 15-count package. The label states each delayed-release capsule contains 30 mg Lansoprazole. The label includes lot and expiration information placeholders, NDC 21695-106-15, and identifies Physician Partner as the packager with manufacturing by TAP Pharmaceuticals Inc., Lake Forest, IL. Storage instructions and usage information are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.